The latest press releases from Strata Oncology
Results for “”
Press releases
Strata Oncology Announces Presentations on Proprietary Multivariate Biomarkers at North America Conference on Lung Cancer and San Antonio Breast Cancer Symposium
Strata Oncology Recognized as “Diagnostics Innovation Of The Year” by BioTech Breakthrough Awards
Strata Oncology Announces Appointment of Goz Alhir as Senior Vice President of Commercialization
Strata Oncology Announces New Data Supporting Utility of Immunotherapy Response Score to Guide First-Line Treatment Decisions in Non-small Cell Lung Cancer
Strata Oncology Receives Honorable Mention in Fast Company’s 2023 World Changing Ideas Awards
Strata Oncology Announces Launch and Medicare Coverage for Strata Select, a First-of-its-kind Immunotherapy Test
Strata Oncology Announces Four Abstracts Accepted for Presentation at AACR Annual Meeting 2023
Strata Oncology Announces Publication of Study Validating Clinical Utility of Pan-tumor Predictive Biomarker for Checkpoint Inhibitor Immunotherapy Benefit
Strata Oncology Announces Addition of Gilead as Strata PATH Trial Collaborator
We couldn't find any results for “”. Please try another search.